Contact   |   Login
EquinYar Banner Image
Animal Health >>  EquinYar Feed Supplements >>

GI Foal™

EquinYar™ Classic is based on our proprietary and patent-protected strain of Yarrowia lipolytica yeast ( 5902596870171, 5902596870539 )

EquinYar GIFoal contains Yarrowia lipolytica yeast with prebiotic properties and supports the proper growth of gastrointestinal microflora and reduces the risk of digestive disorders. The addition of omega-3,6 bioesters having anti-inflammatory features and linseed containing mucous substances protects the gastrointestinal tract againts harmful factors and supports the proper passage of intestinal contents. Rice bran ensures proper growth of muslce tissue.



Contact our Customer Support Department to find out how we can address your needs in your market.

Catalog Download:

To download the latest catalog for EquinYar, click here.



Quick Contact

Catalog Download:
To download the latest catalog for EquinYar Feed Supplements, click here.



Deferoxamine Mesylate Market to Witness Robust Expansion by 2029 with Teva api, Chengdu Easton Biopharmaceuticals, Pharmapex Group
The Deferoxamine Mesylate Report is a unique record that gives a total judgment of the market in terms of future patterns, development factors, creation volume, CAGR estimation, net revenue, cost, and industry-approved market data.

Pharmapex's novel mastitis treatment offers hope to world farmers
Efficient feed-based mastitis treatment boosts livestock health with a unique microencapsulated technology.

FDA approves Farxiga to treat type 2 diabetes
The U.S. FDA today approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
© , Pharmapex USA, A member of Apex Group of Companies, All Rights Reserved.